COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 1069: Articles 10681-10690  | Next

Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike protein vaccine: a randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study).
Hernandez-Bernal, F., Ricardo-Cobas, M. d. C., Martin-Bauta, Y., Navarro-Rodriguez, Z., Pinera-Martinez, M., Quintana-Guerra, J., Urrutia-Perez, K., Urrutia-Perez, K., Chavez-Chong, C. O., Azor-Hernandez, J. L., Rodriguez-Reinoso, J. L., Lobaina-Lambert, L., Colina-Avila, E., Bizet-Almeida, J., Rodriguez-Nuviola, J., del Valle-Pinera, S., Ramirez-Dominguez, M., Tablada-Ferreiro, E., Alonso-Valdes, M., Lemos-Perez, G., Palenzuela-Diaz, A., Noa-Romero, E., Limonta-Fernandez, M., Fernandez-Avila, J. M., Ali-Mros, N., del Toro-Lahera, L., Remedios-Reyes, R., Ayala-Avila, M., Muzio-Gonzalez, V. L.
10.1101/2021.11.30.21267047 — Posted: 2021-11-30
SARS-CoV-2 genomic monitoring in the Sao Paulo State unveils new sublineages of the AY.43 strain
Lima, A. R. J., Ribeiro, G., Viala, V. L., Lima, L. P. O., Martins, A. J., Barros, C., Marqueze, E., Bernardino, J., Moretti, D., Rodrigues, E. S., Santos, E. V., Brassaloti, R. A., Cassano, R., Mariani, P., Clemente, L. G., Assato, P. A., Costa, F. A., Poleti, M. D., Lesbon, J. C. C., Mattos, E. C., Banho, C. A., Sacchetto, L. S., Moraes, M. M., Palmieri, M., Silva, F. E., Grotto, R. T., Souza-Neto, J. A., Giovanetti, M., Alcantara, L., Nogueira, M. L., Fukumasu, H., Coutinho, L. L., Kashima, S., Neto, R. M., Covas, D. T., Slavov, S. N., Elias, M. C., Sampaio, S. C.
10.1101/2021.11.29.21266819 — Posted: 2021-11-30
Incorporating the mutational landscape of SARS-COV-2 variants and case-dependent vaccination rates into epidemic models
Chowdhury, M. M., Islam, M. R., Hossain, M. S., Tabassum, N., Peace, A.
10.1101/2021.11.28.21266882 — Posted: 2021-11-29
Proof of concept continuous event logging in living cells
Shur, A., Murray, R. M.
10.1101/225151 — Posted: 2021-11-29
Anticipating future SARS-CoV-2 variants of concern through ab initio quantum mechanical modeling
Zaccaria, M., Genovese, L., Farzan, M., Dawson, W., Nakajima, T., Johnson, W. E., Momeni, B.
10.1101/2021.11.25.470044 — Posted: 2021-11-29
Transient adverse events after REGN-CoV2 administration for mild COVID-19 patients and their potential predictive factors: a single center analysis
Kano, G., Taniguchi, K., Oue, Y.
10.1101/2021.11.29.21266623 — Posted: 2021-11-29
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
Imbrechts, M., Maes, W., Ampofo, L., Van den Berghe, N., Calcoen, B., Van Looveren, D., Noppen, S., Hollevoet, K., Vercruysse, T., Zhang, X., Abdelnabi, R., Foo, C. S.-Y., Thibaut, H. J., Jochmans, D., Ven, K., Lammertyn, J., Vanhoorelbeke, K., Callewaert, N., De Munter, P., Schols, D., Neyts, J., Declerck, P., Geukens, N.
10.1101/2021.11.25.470011 — Posted: 2021-11-29
Evaluating the impact of a pulse oximetry remote monitoring programme on mortality and healthcare utilisation in patients with covid-19 assessed in Accident and Emergency departments in England: a retrospective matched cohort study
Beaney, T., Clarke, J., Alboksmaty, A., Flott, K., Fowler, A., Benger, J. R., Aylin, P., Elkin, S., Darzi, A., Neves, A. L.
10.1101/2021.11.25.21266848 — Posted: 2021-11-29
Unequal impact of the COVID-19 pandemic on excess deaths, life expectancy, and premature mortality across Spanish regions in 2020 and 2021
Islam, N., Lopez, F. J. G., Jdanov, D. A., Royo-Bordonada, M. A., Khunti, K., Lewington, S., Lacey, B., White, M., Morris, E. J., Zunzunegui, M. V.
10.1101/2021.11.29.21266617 — Posted: 2021-11-29
Deficits in planned hospital care for vulnerable adolescents in England during the COVID-19 pandemic: analysis of linked administrative data
Mc Grath-Lone, L., Etoori, D., Gilbert, R., Harron, K., Woodman, J., Blackburn, R.
10.1101/2021.11.29.21266996 — Posted: 2021-11-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).